Preimplantation genetic diagnosis: an update on current technologies and ethical considerations

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Abstract: The aim of reproductive medicine is to support the birth of healthy children. Advances in assisted reproductive technologies and genetic analysis have led to the introduction of preimplantation genetic diagnosis (PGD) for embryos. Indications for PGD have been a major topic in the fields of ethics and law. Concerns vary by nation, religion, population, and segment, and the continued rapid development of new technologies. In contrast to the ethical augment, technology has been developing at an excessively rapid speed. The most significant recent technological development provides the ability to perform whole genome amplification and sequencing of single embryonic cells by microarray or next-generation sequencing methods. As new affordable technologies are introduced, patients are presented with a growing variety of PGD options. Simultaneously, the ethical guidelines for the indications for testing and handling of genetic information must also rapidly correspond to the changes.

Original languageEnglish
JournalReproductive Medicine and Biology
DOIs
Publication statusAccepted/In press - 2015 Nov 14

Fingerprint

Preimplantation Diagnosis
Technology
Reproductive Medicine
Assisted Reproductive Techniques
Genetic Testing
Religion
Ethics
Embryonic Structures
Parturition
Genome
Guidelines
Population

Keywords

  • Microarray
  • Polymerase chain reaction (PCR)
  • Preimplantation genetic diagnosis (PGD)
  • Preimplantation genetic screening (PGS)
  • Whole genome amplification

ASJC Scopus subject areas

  • Reproductive Medicine
  • Cell Biology

Cite this

@article{c1bd750567564674b93e1db3cd121b48,
title = "Preimplantation genetic diagnosis: an update on current technologies and ethical considerations",
abstract = "Abstract: The aim of reproductive medicine is to support the birth of healthy children. Advances in assisted reproductive technologies and genetic analysis have led to the introduction of preimplantation genetic diagnosis (PGD) for embryos. Indications for PGD have been a major topic in the fields of ethics and law. Concerns vary by nation, religion, population, and segment, and the continued rapid development of new technologies. In contrast to the ethical augment, technology has been developing at an excessively rapid speed. The most significant recent technological development provides the ability to perform whole genome amplification and sequencing of single embryonic cells by microarray or next-generation sequencing methods. As new affordable technologies are introduced, patients are presented with a growing variety of PGD options. Simultaneously, the ethical guidelines for the indications for testing and handling of genetic information must also rapidly correspond to the changes.",
keywords = "Microarray, Polymerase chain reaction (PCR), Preimplantation genetic diagnosis (PGD), Preimplantation genetic screening (PGS), Whole genome amplification",
author = "Kou Sueoka",
year = "2015",
month = "11",
day = "14",
doi = "10.1007/s12522-015-0224-6",
language = "English",
journal = "Reproductive Medicine and Biology",
issn = "1445-5781",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Preimplantation genetic diagnosis

T2 - an update on current technologies and ethical considerations

AU - Sueoka, Kou

PY - 2015/11/14

Y1 - 2015/11/14

N2 - Abstract: The aim of reproductive medicine is to support the birth of healthy children. Advances in assisted reproductive technologies and genetic analysis have led to the introduction of preimplantation genetic diagnosis (PGD) for embryos. Indications for PGD have been a major topic in the fields of ethics and law. Concerns vary by nation, religion, population, and segment, and the continued rapid development of new technologies. In contrast to the ethical augment, technology has been developing at an excessively rapid speed. The most significant recent technological development provides the ability to perform whole genome amplification and sequencing of single embryonic cells by microarray or next-generation sequencing methods. As new affordable technologies are introduced, patients are presented with a growing variety of PGD options. Simultaneously, the ethical guidelines for the indications for testing and handling of genetic information must also rapidly correspond to the changes.

AB - Abstract: The aim of reproductive medicine is to support the birth of healthy children. Advances in assisted reproductive technologies and genetic analysis have led to the introduction of preimplantation genetic diagnosis (PGD) for embryos. Indications for PGD have been a major topic in the fields of ethics and law. Concerns vary by nation, religion, population, and segment, and the continued rapid development of new technologies. In contrast to the ethical augment, technology has been developing at an excessively rapid speed. The most significant recent technological development provides the ability to perform whole genome amplification and sequencing of single embryonic cells by microarray or next-generation sequencing methods. As new affordable technologies are introduced, patients are presented with a growing variety of PGD options. Simultaneously, the ethical guidelines for the indications for testing and handling of genetic information must also rapidly correspond to the changes.

KW - Microarray

KW - Polymerase chain reaction (PCR)

KW - Preimplantation genetic diagnosis (PGD)

KW - Preimplantation genetic screening (PGS)

KW - Whole genome amplification

UR - http://www.scopus.com/inward/record.url?scp=84947093539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947093539&partnerID=8YFLogxK

U2 - 10.1007/s12522-015-0224-6

DO - 10.1007/s12522-015-0224-6

M3 - Article

AN - SCOPUS:84947093539

JO - Reproductive Medicine and Biology

JF - Reproductive Medicine and Biology

SN - 1445-5781

ER -